Dexcom Income Statement (2010-2026) | DXCM

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	595.10M	650.20M	698.20M	628.80M	696.20M	769.60M	815.20M	741.50M	871.30M	975.00M	1,034.50M	921.00M	1,004.30M	994.20M	1,113.50M	1,036.00M	1,157.10M	1,209.30M	1,259.60M	1,191.90M
Cost of Revenue (Quarter)	178.00M	203.30M	225.60M	230.70M	246.70M	275.40M	273.90M	278.90M	324.90M	351.70M	377.90M	359.10M	377.60M	400.40M	457.70M	447.00M	468.30M	477.90M	466.90M	441.60M
Gross Profit (Quarter)	417.10M	446.90M	472.60M	398.10M	449.50M	494.20M	541.30M	462.60M	546.40M	623.30M	656.60M	561.90M	626.70M	593.80M	655.80M	589.00M	688.80M	731.40M	792.70M	750.30M
Operating items
Amortization - Intangibles (Quarter)	0.50M	1.30M	1.40M	2.00M	1.90M	1.80M	1.80M	1.80M	1.70M	1.70M
Research & Development (Quarter)	129.10M	128.80M	149.80M	135.90M	121.70M	110.30M	116.30M	119.00M	119.30M	131.40M	136.10M	141.50M	136.00M	135.40M	139.50M	145.20M	148.20M	157.50M	148.20M	145.30M
Selling, General & Administrative (Quarter)	186.50M	198.50M	237.40M	218.90M	248.90M	234.60M	305.30M	296.40M	299.00M	286.40M	303.60M	319.30M	332.70M	306.40M	327.40M	310.10M	328.00M	331.40M	321.50M	349.70M
Other Operating Expenses (Quarter)	0.50M	1.30M	84.80M	2.00M	1.90M	1.80M	-5.70M
Operating Expenses (Quarter)	316.10M	328.60M	472.00M	356.80M	372.50M	346.70M	415.90M	415.40M	418.30M	417.80M	439.70M	460.80M	468.70M	441.80M	466.90M	455.30M	476.20M	488.90M	469.70M	495.00M
Operating Income (Quarter)	101.00M	118.30M	0.60M	41.30M	77.00M	147.50M	125.40M	47.20M	128.10M	205.50M	216.90M	101.10M	158.00M	152.00M	188.90M	133.70M	212.60M	242.50M	323.00M	255.30M
EBIT (Quarter)	101.00M	118.30M	0.60M	41.30M	77.00M	147.50M	125.40M	47.20M	128.10M	205.50M	216.90M	101.10M	158.00M	152.00M	188.90M	133.70M	212.60M	242.50M	323.00M	255.30M
Non-operating items
Interest & Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.90M	-1.70M	-8.30M	-0.80M	3.00M	-1.30M	8.00M	17.30M	31.20M	34.90M	29.30M	31.40M	29.80M	25.40M	22.40M	20.60M	28.50M	109.80M	17.70M	14.20M
Non Operating Income (Quarter)	0.90M	-1.70M	-8.30M	-0.80M	3.00M	-1.30M	8.00M	17.30M	31.20M	34.90M	29.30M	31.40M	29.80M	25.40M	22.40M	20.60M	28.50M	109.80M	17.70M	14.20M
Net income details
EBT (Quarter)	97.10M	112.00M	6.40M	36.10M	75.30M	146.20M	133.20M	64.50M	159.30M	240.40M	246.20M	132.50M	187.80M	177.40M	211.30M	154.30M	241.10M	352.30M	340.70M	269.50M
Tax Provisions (Quarter)	18.70M	24.70M	11.70M	-61.20M	24.40M	45.00M	41.40M	15.90M	43.40M	119.70M	-10.10M	-13.90M	44.30M	42.80M	59.60M	48.90M	61.30M	68.50M	73.40M	70.00M
Profit After Tax (Quarter)	78.40M	87.30M	-5.30M	97.30M	50.90M	101.20M	91.80M	48.60M	115.90M	120.70M	256.30M	146.40M	143.50M	134.60M	151.70M	105.40M	179.80M	283.80M	267.30M	199.50M
Income from Continuing Operations (Quarter)	78.40M	87.30M	-5.30M	97.30M	50.90M	101.20M	91.80M	48.60M	115.90M	120.70M	256.30M	146.40M	143.50M	134.60M	151.70M	105.40M	179.80M	283.80M	267.30M	199.50M
Consolidated Net Income (Quarter)	78.40M	87.30M	-5.30M	97.30M	50.90M	101.20M	91.80M	48.60M	115.90M	120.70M	256.30M	146.40M	143.50M	134.60M	151.70M	105.40M	179.80M	283.80M	267.30M	199.50M
Income towards Parent Company (Quarter)	78.40M	87.30M	-5.30M	97.30M	50.90M	101.20M	91.80M	48.60M	115.90M	120.70M	256.30M	146.40M	143.50M	134.60M	151.70M	105.40M	179.80M	283.80M	267.30M	199.50M
Net Income towards Common Stockholders (Quarter)	78.40M	87.30M	-5.30M	97.30M	50.90M	101.20M	91.80M	48.60M	115.90M	120.70M	256.30M	146.40M	143.50M	134.60M	151.70M	105.40M	179.80M	283.80M	267.30M	199.50M
Additional items
EPS (Basic) (Quarter)	0.20	0.23	-0.01	0.25	0.13	0.26	0.24	0.13	0.30	0.31	0.66	0.38	0.36	0.34	0.38	0.27	0.46	0.73	0.69	0.52
EPS (Weighted Average and Diluted) (Quarter)	0.19	0.21	-0.01	0.23	0.12	0.24	0.22	0.12	0.28	0.29	0.61	0.36	0.35	0.34	0.38	0.27	0.45	0.70	0.67	0.51
Shares Outstanding (Weighted Average) (Quarter)	386.90M	387.40M	386.90M	388.90M	390.70M	390.40M	389.40M	386.70M	386.70M	386.70M	386.00M	390.20M	394.80M	394.60M	393.60M	391.10M	391.60M	391.10M	390.20M	385.10M
Shares Outstanding (Diluted Average) (Quarter)	427.10M	427.90M	428.80M	428.70M	421.40M	425.80M	427.50M	418.50M	431.50M	428.30M	425.50M	416.70M	416.80M	410.20M	412.70M	407.50M	407.80M	407.70M	405.50M	393.60M
EBITDA (Quarter)	101.00M	118.30M	0.60M	41.30M	77.00M	147.50M	125.40M	47.20M	128.10M	205.50M	216.90M	101.10M	158.00M	152.00M	188.90M	133.70M	212.60M	242.50M	323.00M	255.30M
Interest Expenses (Quarter)	4.80M	4.60M	4.70M	4.60M	4.70M	4.60M	4.70M	4.60M	5.90M
Tax Rate (Quarter)	19.26%	22.05%	182.81%	-169.53%	32.40%	30.78%	31.08%	24.65%	27.24%	49.79%	-4.10%	-10.49%	23.59%	24.13%	28.21%	31.69%	25.43%	19.44%	21.54%	25.97%

Research Tools

Dexcom Income Statement (2010-2026) | DXCM

Create an account

Sign In

Reset Password